Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers

Rex Yung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lung cancer (LC) is the leading cause of cancer mortality, and even as the annual incidence of LC may have reached a plateau in the United States, making it the second most prevalent cancer for both men and women. LC mortality continues to exceed the deaths from breast, prostate and colon cancers combined (1). of note, LC mortality as a single cause of death is even greater than deaths due to cerebral vascular accidents, hence making it the second single cause of death in the United States, after heart diseases. The widespread availability of high-speed multi-slice detector computer-axial tomography (MDCT) scanners, implementation of prospective controlled and uncontrolled LC screening studies (2, 3), unwarranted proprietary “screening” services and incidental findings on scans performed for other thoracoabdominal indications have led to the frequent finding of lung nodules. If experience with other early detection tests such as mammography and prostate-specific antigen is any indication, there will be an expected increase in the diagnosis of “early stage” LCs (1), although whether this would lead to meaningful reduction in disease-specific mortality remains to be seen as there is much debate about the potential efficacy of such screenings (4–6). Parallel with the improvement in diagnostic imaging are advances made in the fields of cancer diagnosis, including real-time image-guided tissue biopsies and molecular characterization of thoracic malignancies.

Original languageEnglish (US)
Title of host publicationInterventional Oncology: Principles and Practice
PublisherCambridge University Press
Pages424-439
Number of pages16
ISBN (Print)9780511722226, 9780521864138
DOIs
StatePublished - Jan 1 2008

Fingerprint

Lung Neoplasms
Epidemiology
Mortality
Cause of Death
Neoplasms
Image-Guided Biopsy
Incidental Findings
Diagnostic Imaging
Mammography
Prostate-Specific Antigen
Early Detection of Cancer
Colonic Neoplasms
Accidents
Blood Vessels
Heart Diseases
Prostatic Neoplasms
Thorax
Tomography
Breast Neoplasms
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yung, R. (2008). Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers. In Interventional Oncology: Principles and Practice (pp. 424-439). Cambridge University Press. https://doi.org/10.1017/CBO9780511722226.036

Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers. / Yung, Rex.

Interventional Oncology: Principles and Practice. Cambridge University Press, 2008. p. 424-439.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yung, R 2008, Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers. in Interventional Oncology: Principles and Practice. Cambridge University Press, pp. 424-439. https://doi.org/10.1017/CBO9780511722226.036
Yung R. Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers. In Interventional Oncology: Principles and Practice. Cambridge University Press. 2008. p. 424-439 https://doi.org/10.1017/CBO9780511722226.036
Yung, Rex. / Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers. Interventional Oncology: Principles and Practice. Cambridge University Press, 2008. pp. 424-439
@inbook{967d25467da642ca88b3e34478f37d34,
title = "Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers",
abstract = "Lung cancer (LC) is the leading cause of cancer mortality, and even as the annual incidence of LC may have reached a plateau in the United States, making it the second most prevalent cancer for both men and women. LC mortality continues to exceed the deaths from breast, prostate and colon cancers combined (1). of note, LC mortality as a single cause of death is even greater than deaths due to cerebral vascular accidents, hence making it the second single cause of death in the United States, after heart diseases. The widespread availability of high-speed multi-slice detector computer-axial tomography (MDCT) scanners, implementation of prospective controlled and uncontrolled LC screening studies (2, 3), unwarranted proprietary “screening” services and incidental findings on scans performed for other thoracoabdominal indications have led to the frequent finding of lung nodules. If experience with other early detection tests such as mammography and prostate-specific antigen is any indication, there will be an expected increase in the diagnosis of “early stage” LCs (1), although whether this would lead to meaningful reduction in disease-specific mortality remains to be seen as there is much debate about the potential efficacy of such screenings (4–6). Parallel with the improvement in diagnostic imaging are advances made in the fields of cancer diagnosis, including real-time image-guided tissue biopsies and molecular characterization of thoracic malignancies.",
author = "Rex Yung",
year = "2008",
month = "1",
day = "1",
doi = "10.1017/CBO9780511722226.036",
language = "English (US)",
isbn = "9780511722226",
pages = "424--439",
booktitle = "Interventional Oncology: Principles and Practice",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Epidemiology, diagnosis, staging and the medical-surgical management of lung cancers

AU - Yung, Rex

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Lung cancer (LC) is the leading cause of cancer mortality, and even as the annual incidence of LC may have reached a plateau in the United States, making it the second most prevalent cancer for both men and women. LC mortality continues to exceed the deaths from breast, prostate and colon cancers combined (1). of note, LC mortality as a single cause of death is even greater than deaths due to cerebral vascular accidents, hence making it the second single cause of death in the United States, after heart diseases. The widespread availability of high-speed multi-slice detector computer-axial tomography (MDCT) scanners, implementation of prospective controlled and uncontrolled LC screening studies (2, 3), unwarranted proprietary “screening” services and incidental findings on scans performed for other thoracoabdominal indications have led to the frequent finding of lung nodules. If experience with other early detection tests such as mammography and prostate-specific antigen is any indication, there will be an expected increase in the diagnosis of “early stage” LCs (1), although whether this would lead to meaningful reduction in disease-specific mortality remains to be seen as there is much debate about the potential efficacy of such screenings (4–6). Parallel with the improvement in diagnostic imaging are advances made in the fields of cancer diagnosis, including real-time image-guided tissue biopsies and molecular characterization of thoracic malignancies.

AB - Lung cancer (LC) is the leading cause of cancer mortality, and even as the annual incidence of LC may have reached a plateau in the United States, making it the second most prevalent cancer for both men and women. LC mortality continues to exceed the deaths from breast, prostate and colon cancers combined (1). of note, LC mortality as a single cause of death is even greater than deaths due to cerebral vascular accidents, hence making it the second single cause of death in the United States, after heart diseases. The widespread availability of high-speed multi-slice detector computer-axial tomography (MDCT) scanners, implementation of prospective controlled and uncontrolled LC screening studies (2, 3), unwarranted proprietary “screening” services and incidental findings on scans performed for other thoracoabdominal indications have led to the frequent finding of lung nodules. If experience with other early detection tests such as mammography and prostate-specific antigen is any indication, there will be an expected increase in the diagnosis of “early stage” LCs (1), although whether this would lead to meaningful reduction in disease-specific mortality remains to be seen as there is much debate about the potential efficacy of such screenings (4–6). Parallel with the improvement in diagnostic imaging are advances made in the fields of cancer diagnosis, including real-time image-guided tissue biopsies and molecular characterization of thoracic malignancies.

UR - http://www.scopus.com/inward/record.url?scp=84932605724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932605724&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511722226.036

DO - 10.1017/CBO9780511722226.036

M3 - Chapter

AN - SCOPUS:84932605724

SN - 9780511722226

SN - 9780521864138

SP - 424

EP - 439

BT - Interventional Oncology: Principles and Practice

PB - Cambridge University Press

ER -